CD8A and neoplasm: For instance, the neoadjuvant vaccination strategy employed in the GBM6-AD trial demonstrated that preoperative vaccination could prime the immune system more effectively than postoperative approaches alone, leading to greater CD8+ T cell infiltration into the tumor microenvironment [35].